Elderly Patients with Mantle Cell Lymphoma Need to be More Intensively Treated
The future for patients with mantle cell lymphoma is to be treated with novel targeted drugs upfront and also immunotherapy. This also includes elderly patients, who have a much worse prognosis, says professor Ingrid Glimelius, Uppsala University, in this MEDtalk from EHA 2024.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in